ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Health Petitions and Advocacy
Petitions, Press Releases and Position Statements
How transmen testosterone access advocacy can protect current TRT telemedicine access for all men.
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 248480" data-attributes="member: 3"><p><strong>A new proposed rule may complicate access of TRT products via telemedicine. </strong></p><p>Testosterone is a Schedule 3 controlled substance.</p><p></p><p>Under the<strong> Ryan Haight Online Pharmacy Consumer Protection Act of 2008</strong> and Drug Enforcement Administration’s (DEA) implementing regulations, after a patient and a</p><p>practitioner have had an in-person medical evaluation, that practitioner may use telehealth to prescribe that patient any prescription for a controlled medication that the practitioner deems</p><p>medically necessary. The Ryan Haight Act and DEA’s implementing regulations do not apply to other forms of telemedicine, telehealth, or telepsychiatry that are not otherwise</p><p>addressed in the Controlled Substances Act. <strong>This proposed rule applies only in limited circumstances when the prescribing practitioner wishes to prescribe controlled medications via the practice of telemedicine and has not otherwise conducted an in-person medical evaluation prior to the issuance of the prescription.</strong></p><p></p><p> The Drug Enforcement Agency and the Department of Health and Human Services last month announced a <a href="https://www.govinfo.gov/content/pkg/FR-2023-03-01/pdf/2023-04248.pdf" target="_blank">proposed rule</a> to loosen some of the in-person prescription requirements once the health emergency ends, in May.</p><p></p><ul> <li data-xf-list-type="ul">Providers could make an initial 30-day prescription through telemedicine, <strong>but would then require an in-person visit.</strong></li> <li data-xf-list-type="ul"><strong>The agency is also proposing an option for patients to see a DEA-registered practitioner who could then make a referral to a provider who can continue treatments via telehealth.</strong></li> </ul><p></p><p>Believe it or not, access to gender affirming TRT may become one of the main arguments against the proposed new regulations.</p><p></p><p>Read here:</p><p></p><p>[URL unfurl="true"]https://www.axios.com/2023/03/15/unwinding-emergency-gender-affirming-care[/URL]</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 248480, member: 3"] [B]A new proposed rule may complicate access of TRT products via telemedicine. [/B] Testosterone is a Schedule 3 controlled substance. Under the[B] Ryan Haight Online Pharmacy Consumer Protection Act of 2008[/B] and Drug Enforcement Administration’s (DEA) implementing regulations, after a patient and a practitioner have had an in-person medical evaluation, that practitioner may use telehealth to prescribe that patient any prescription for a controlled medication that the practitioner deems medically necessary. The Ryan Haight Act and DEA’s implementing regulations do not apply to other forms of telemedicine, telehealth, or telepsychiatry that are not otherwise addressed in the Controlled Substances Act. [B]This proposed rule applies only in limited circumstances when the prescribing practitioner wishes to prescribe controlled medications via the practice of telemedicine and has not otherwise conducted an in-person medical evaluation prior to the issuance of the prescription.[/B] The Drug Enforcement Agency and the Department of Health and Human Services last month announced a [URL='https://www.govinfo.gov/content/pkg/FR-2023-03-01/pdf/2023-04248.pdf']proposed rule[/URL] to loosen some of the in-person prescription requirements once the health emergency ends, in May. [LIST] [*]Providers could make an initial 30-day prescription through telemedicine, [B]but would then require an in-person visit.[/B] [*][B]The agency is also proposing an option for patients to see a DEA-registered practitioner who could then make a referral to a provider who can continue treatments via telehealth.[/B] [/LIST] Believe it or not, access to gender affirming TRT may become one of the main arguments against the proposed new regulations. Read here: [URL unfurl="true"]https://www.axios.com/2023/03/15/unwinding-emergency-gender-affirming-care[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Health Petitions and Advocacy
Petitions, Press Releases and Position Statements
How transmen testosterone access advocacy can protect current TRT telemedicine access for all men.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top